semaglutide cardiovascular outcomes study 2025 news and by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial Recent study finds that semaglutide

Who Can Receive Weight Loss Medications Weight loss medications are typically prescribed for adults with a BMI of 30 or higher, or a BMI of 27 or higher in conjunction with conditions like type 2 diabetes or high blood pressure

Senoo-Matsuda, N., Hartman, P

As a result, compounded semaglutide may have inconsistencies in dosage, effectiveness, and safety, potentially introducing harmful impurities or inaccurate dosing

Geetika Arora, an endocrinologist at Northwell's Phelps Hospital, puts it simply: "The trade-off comes down to convenience versus maximum weight loss." In a Lilly-funded trial published by The Lancet, patients on 12 to 36 milligrams of orforglipron lost an average of 15 to 20 pounds, compared with 8 to 11 pounds for those on 7 to 14 milligrams of Rybelsus

Use one per injection and dispose of it in a sharps bin immediately